Lista de obras -

A long-term follow-up study on biochemical and clinical biomarkers of response to interferon beta-1b treatment in relapsing-remitting multiple sclerosis

artículo científico publicado en 2020

Anti-interferon-beta antibodies in Polish multiple sclerosis patients: prevalence and clinical significance in a long-term prospective study

scientific article published on 17 October 2019

Autoimmune response in lung cancer patients with neurological paraneoplastic syndromes

artículo científico publicado en 2019

Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies — the Polish experience

artículo científico publicado en 2021

Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing−remitting multiple sclerosis patients

artículo científico publicado en 2010

Cognitive deficit is related to immune-cell beta-NGF in multiple sclerosis patients.

artículo científico

Distinct regional brain atrophy pattern in multiple sclerosis and neuropsychiatric systemic lupus erythematosus patients

artículo científico publicado en 2018

Emerging disease-modifying oral therapies for multiple sclerosis

artículo científico publicado en 2010

Evaluation of clinical prognostic factors in Polish interferon beta-1b treated multiple sclerosis patients

scientific article published on 03 December 2019

Expression of small heat shock proteins in exosomes from patients with gynecologic cancers

scientific article published on 08 July 2019

Immune Cell Neurotrophin Production Is Associated with Subcortical Brain Atrophy in Neuropsychiatric Systemic Lupus Erythematosus Patients.

artículo científico publicado en 2018

Immune cell NT-3 expression is associated with brain atrophy in multiple sclerosis patients.

artículo científico publicado en 2011

Immune-cell BDNF expression in treatment-naïve relapsing-remitting multiple sclerosis patients and following one year of immunomodulation therapy.

artículo científico publicado en 2018

Increased Serum CD14 Level Is Associated with Depletion of TNF-α in Monocytes in Migraine Patients during Interictal Period.

artículo científico publicado en 2017

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management

artículo científico publicado en 2020

Pathological findings in central nervous system demyelination associated with infliximab

artículo científico publicado en 2019

Recommendations for neurological, obstetrical and gynaecological care in women with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society

artículo científico publicado en 2020

Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies

artículo científico publicado en 2022

Serum sPECAM-1 and sVCAM-1 levels are associated with conversion to multiple sclerosis in patients with optic neuritis.

artículo científico publicado en 2016

Spatial distribution of white matter degenerative lesions and cognitive dysfunction in relapsing-remitting multiple sclerosis patients

scientific article published on 11 February 2019

Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients

artículo científico publicado en 2017

Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland

artículo científico publicado en 2021

The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives

artículo científico publicado en 2016

The Levels of Circulating Proangiogenic Factors in Migraineurs.

artículo científico publicado en 2017

The associations between serum vascular endothelial growth factor, tumor necrosis factor and interleukin 4 with the markers of blood-brain barrier breakdown in patients with paraneoplastic neurological syndromes

scientific article published on 29 October 2018

The cross-reactivity of binding antibodies with different interferon beta formulations used as disease-modifying drugs in multiple sclerosis patients.

artículo científico publicado en 2016

The role of neurotrophins in multiple sclerosis-pathological and clinical implications

artículo científico publicado en 2012

sNCAM as a specific marker of peripheral demyelination.

artículo científico publicado en 2017

Lista de obras de

A long-term follow-up study on biochemical and clinical biomarkers of response to interferon beta-1b treatment in relapsing-remitting multiple sclerosis

Anti-interferon-beta antibodies in Polish multiple sclerosis patients: prevalence and clinical significance in a long-term prospective study

Autoimmune response in lung cancer patients with neurological paraneoplastic syndromes

Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies — the Polish experience

Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing−remitting multiple sclerosis patients

Cognitive deficit is related to immune-cell beta-NGF in multiple sclerosis patients.

Distinct regional brain atrophy pattern in multiple sclerosis and neuropsychiatric systemic lupus erythematosus patients

Emerging disease-modifying oral therapies for multiple sclerosis

Evaluation of clinical prognostic factors in Polish interferon beta-1b treated multiple sclerosis patients

Expression of small heat shock proteins in exosomes from patients with gynecologic cancers

Immune Cell Neurotrophin Production Is Associated with Subcortical Brain Atrophy in Neuropsychiatric Systemic Lupus Erythematosus Patients.

Immune cell NT-3 expression is associated with brain atrophy in multiple sclerosis patients.

Immune-cell BDNF expression in treatment-naïve relapsing-remitting multiple sclerosis patients and following one year of immunomodulation therapy.

Increased Serum CD14 Level Is Associated with Depletion of TNF-α in Monocytes in Migraine Patients during Interictal Period.

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management

Pathological findings in central nervous system demyelination associated with infliximab

Recommendations for neurological, obstetrical and gynaecological care in women with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society

Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies

Serum sPECAM-1 and sVCAM-1 levels are associated with conversion to multiple sclerosis in patients with optic neuritis.

Spatial distribution of white matter degenerative lesions and cognitive dysfunction in relapsing-remitting multiple sclerosis patients

Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients

Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland

The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives

The Levels of Circulating Proangiogenic Factors in Migraineurs.

The associations between serum vascular endothelial growth factor, tumor necrosis factor and interleukin 4 with the markers of blood-brain barrier breakdown in patients with paraneoplastic neurological syndromes

The cross-reactivity of binding antibodies with different interferon beta formulations used as disease-modifying drugs in multiple sclerosis patients.

The role of neurotrophins in multiple sclerosis-pathological and clinical implications

sNCAM as a specific marker of peripheral demyelination.